.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Novartis
Federal Trade Commission
QuintilesIMS
Farmers Insurance
Medtronic
Accenture
Merck
Queensland Health

Generated: December 12, 2017

DrugPatentWatch Database Preview

Ketamine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ketamine hydrochloride and what is the scope of ketamine hydrochloride patent protection?

Ketamine hydrochloride
is the generic ingredient in two branded drugs marketed by Par Sterile Products, Hospira, Mylan Institutional, and West-ward Pharms Int, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for ketamine hydrochloride. Seven suppliers are listed for this compound.

Pharmacology for ketamine hydrochloride

Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia

Medical Subject Heading (MeSH) Categories for ketamine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Mylan InstitutionalKETAMINE HYDROCHLORIDEketamine hydrochlorideINJECTABLE;INJECTION076092-001Sep 30, 2008APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par Sterile ProductsKETALARketamine hydrochlorideINJECTABLE;INJECTION016812-002Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntKETAMINE HYDROCHLORIDEketamine hydrochlorideINJECTABLE;INJECTION074524-001Mar 22, 1996APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par Sterile ProductsKETALARketamine hydrochlorideINJECTABLE;INJECTION016812-003Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Par Sterile ProductsKETALARketamine hydrochlorideINJECTABLE;INJECTION016812-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
HospiraKETAMINE HYDROCHLORIDEketamine hydrochlorideINJECTABLE;INJECTION074549-001Jun 27, 1996APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan InstitutionalKETAMINE HYDROCHLORIDEketamine hydrochlorideINJECTABLE;INJECTION076092-003Oct 25, 2002APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan InstitutionalKETAMINE HYDROCHLORIDEketamine hydrochlorideINJECTABLE;INJECTION076092-002Dec 28, 2001APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HospiraKETAMINE HYDROCHLORIDEketamine hydrochlorideINJECTABLE;INJECTION074549-002Jun 27, 1996APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntKETAMINE HYDROCHLORIDEketamine hydrochlorideINJECTABLE;INJECTION074524-002Mar 22, 1996APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Harvard Business School
Cerilliant
Federal Trade Commission
Citi
Moodys
Express Scripts
Chubb
Covington
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot